Cargando…
Treatment adherence redefined: a critical analysis of technotherapeutics
GAGNON M, JACOB JD and GUTA A. Nursing Inquiry 2013; 20: 60–70 Treatment adherence redefined: a critical analysis of technotherapeutics Treatment adherence issues in the context of chronic illnesses have become an important concern worldwide and a top priority in the field of health-care. The develo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579230/ https://www.ncbi.nlm.nih.gov/pubmed/22381079 http://dx.doi.org/10.1111/j.1440-1800.2012.00595.x |
_version_ | 1782260106325393408 |
---|---|
author | Gagnon, Marilou Jacob, Jean Daniel Guta, Adrian |
author_facet | Gagnon, Marilou Jacob, Jean Daniel Guta, Adrian |
author_sort | Gagnon, Marilou |
collection | PubMed |
description | GAGNON M, JACOB JD and GUTA A. Nursing Inquiry 2013; 20: 60–70 Treatment adherence redefined: a critical analysis of technotherapeutics Treatment adherence issues in the context of chronic illnesses have become an important concern worldwide and a top priority in the field of health-care. The development of devices that will allow healthcare providers to track treatment adherence and monitor physiological parameters with exact precision raises important questions and concerns. The aim of this study is to interrogate the use of these new technological devices which allow for previously unavailable data to be recorded on an ongoing basis and transmitted via a tiny microchip inserted into the body. Drawing on the work of Michel Foucault, we analyze how this anatomo-political and bio-political instrument serves to discipline chronically ill individuals and govern the health of entire populations who suffer from chronic conditions. To support our analysis, this article comprises three sections. First, we provide an overview of treatment adherence and technotherapeutics. Then, we explain how technotherapeutics concern the government of bodies and conducts at the individual level and population level more generally. Lastly, we provide an example of how this analysis can be connected to routine nursing practice in the field of HIV. |
format | Online Article Text |
id | pubmed-3579230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35792302013-02-25 Treatment adherence redefined: a critical analysis of technotherapeutics Gagnon, Marilou Jacob, Jean Daniel Guta, Adrian Nurs Inq Feature Articles GAGNON M, JACOB JD and GUTA A. Nursing Inquiry 2013; 20: 60–70 Treatment adherence redefined: a critical analysis of technotherapeutics Treatment adherence issues in the context of chronic illnesses have become an important concern worldwide and a top priority in the field of health-care. The development of devices that will allow healthcare providers to track treatment adherence and monitor physiological parameters with exact precision raises important questions and concerns. The aim of this study is to interrogate the use of these new technological devices which allow for previously unavailable data to be recorded on an ongoing basis and transmitted via a tiny microchip inserted into the body. Drawing on the work of Michel Foucault, we analyze how this anatomo-political and bio-political instrument serves to discipline chronically ill individuals and govern the health of entire populations who suffer from chronic conditions. To support our analysis, this article comprises three sections. First, we provide an overview of treatment adherence and technotherapeutics. Then, we explain how technotherapeutics concern the government of bodies and conducts at the individual level and population level more generally. Lastly, we provide an example of how this analysis can be connected to routine nursing practice in the field of HIV. Blackwell Publishing Ltd 2013-03 /pmc/articles/PMC3579230/ /pubmed/22381079 http://dx.doi.org/10.1111/j.1440-1800.2012.00595.x Text en © 2012 Blackwell Publishing Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Feature Articles Gagnon, Marilou Jacob, Jean Daniel Guta, Adrian Treatment adherence redefined: a critical analysis of technotherapeutics |
title | Treatment adherence redefined: a critical analysis of technotherapeutics |
title_full | Treatment adherence redefined: a critical analysis of technotherapeutics |
title_fullStr | Treatment adherence redefined: a critical analysis of technotherapeutics |
title_full_unstemmed | Treatment adherence redefined: a critical analysis of technotherapeutics |
title_short | Treatment adherence redefined: a critical analysis of technotherapeutics |
title_sort | treatment adherence redefined: a critical analysis of technotherapeutics |
topic | Feature Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579230/ https://www.ncbi.nlm.nih.gov/pubmed/22381079 http://dx.doi.org/10.1111/j.1440-1800.2012.00595.x |
work_keys_str_mv | AT gagnonmarilou treatmentadherenceredefinedacriticalanalysisoftechnotherapeutics AT jacobjeandaniel treatmentadherenceredefinedacriticalanalysisoftechnotherapeutics AT gutaadrian treatmentadherenceredefinedacriticalanalysisoftechnotherapeutics |